Suzhou MedicalSystem Technology Co., Ltd.(603990.SS)
No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 308 | 354 | 306 | 618 | 464 | 300 | N/A | N/A |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 35 | 42 | 34 | -269 | -279 | 39 | N/A | N/A |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Suzhou MedicalSystem Technology Co., Ltd., established in Suzhou, China, in 2005, is a company dedicated to developing and implementing advanced clinical information technology and digital hospital management solutions throughout China. Their product portfolio primarily features the "DoCare" suite of systems: The DoCare anesthesia clinical information system is tailored for the perioperative environment, offering an integrated platform that streamlines, digitalizes, automates, and intelligently manages clinical workflows during surgical procedures. The DoCare intensive auxiliary diagnosis clinical information system focuses on extracting and scientifically analyzing treatment data from ICU patients. It integrates diverse medical information, including treatment details, inspection results, nursing records, and doctor's orders, to support diagnosis and decision-making. The DoCare operative medical behavior management system provides intelligent oversight for operating room resources and staff activities. The DoCare emergency clinical information system offers comprehensive management for emergency care services. This spans the entire patient journey, from pre-hospital first aid and initial triage to active rescue, emergency observation, specialized emergency operating rooms and ICUs, and final patient outcomes. The DoCare pre-hospital first aid clinical information system creates a unified digital service platform connecting emergency command centers, medical personnel (doctors, nurses, visiting staff), and patients for pre-hospital care. Beyond these core offerings, the company also provides specialized "smart" solutions for operating theaters (OT), intensive care units (ICUs), and emergency departments. Additionally, their smart specialty solutions include systems for laminar airflow rooms, clinical pathways, mobile nursing information, and central sterile supply department (CSSD) management.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Suzhou MedicalSystem Technology Co., Ltd. (603990.SS)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Suzhou MedicalSystem Technology Co., Ltd., established in Suzhou, China, in 2005, is a company dedicated to developing and implementing advanced clinical information technology and digital hospital management solutions throughout China. Their product portfolio primarily features the "DoCare" suite of systems: The DoCare anesthesia clinical information system is tailored for the perioperative environment, offering an integrated platform that streamlines, digitalizes, automates, and intelligently manages clinical workflows during surgical procedures. The DoCare intensive auxiliary diagnosis clinical information system focuses on extracting and scientifically analyzing treatment data from ICU patients. It integrates diverse medical information, including treatment details, inspection results, nursing records, and doctor's orders, to support diagnosis and decision-making. The DoCare operative medical behavior management system provides intelligent oversight for operating room resources and staff activities. The DoCare emergency clinical information system offers comprehensive management for emergency care services. This spans the entire patient journey, from pre-hospital first aid and initial triage to active rescue, emergency observation, specialized emergency operating rooms and ICUs, and final patient outcomes. The DoCare pre-hospital first aid clinical information system creates a unified digital service platform connecting emergency command centers, medical personnel (doctors, nurses, visiting staff), and patients for pre-hospital care. Beyond these core offerings, the company also provides specialized "smart" solutions for operating theaters (OT), intensive care units (ICUs), and emergency departments. Additionally, their smart specialty solutions include systems for laminar airflow rooms, clinical pathways, mobile nursing information, and central sterile supply department (CSSD) management.
